Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call
Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21
UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20
Barclays Maintains Equal-Weight on Sabra Health Care REIT, Lowers Price Target to $21
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started
Sabra Health Care REIT: This 5.85% Healthcare REIT Is Undervalued
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
Barclays Maintains Equal-Weight on Sabra Health Care REIT, Raises Price Target to $23
Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. 2026 Q2 - Results - Earnings Call Presentation
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
Raymond James Upgrades Sabra Health Care REIT to Market Perform
Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ...
Sabra Healthcare REIT Q2 Earnings Call Highlights
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. Q2 2026 Earnings Call Summary
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
Sabra Health Care REIT (NASDAQ:SBRA) Q2 Results Beat on Revenue and AFFO Despite Loan Loss Provision
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.